.

ISSN 2063-5346
For urgent queries please contact : +918130348310

A PROSPECTIVE STUDY ON THERAPEUTIC MANAGEMENT & OUTCOME MEASURES IN CARDIO EMBOLIC STROKE PATIENT AT DISCHARGE & FOLLOW-UP

Main Article Content

Mr. Melam Yesuratnam1* , Ch.Reshma Simple2 , Sk.Aashabi3 , T.Daveedu4 , Y.Nagarjuna Reddy
» doi: 10.48047/ecb/2023.12.si5a.0313

Abstract

Introduction: An embolism is a particle that moves from a source and blocks a blood vessel in the body.cardiac sources of embolism may be rare they can cause life-threatening effects such as strokeor heart attack. A cardiac embolism causes a blocked artery, which can affect blood flow. Theyare caused by a cardiac embolus that originates in the heart. A cardiac thrombus is a blood clotthat forms in the heart and is called an embolism when it travels. Depending on where theblockage occurs a person can experience different complications, For example: • A blockage in the heart’s blood vessels can lead toa heart attack. • A blockagein the organs can lead toorgan damage. • A blockage in the limbs lead can lead to a peripheral embolism. When acardiac embolus makes its way into the brain. it causes a cardiac embolism which can cause anembolicstroke. Aim:-“A Prospective Study on Therapeutic Management & out Omeme A sures Incar dio embolic stroke patient at discharge& Follow-Up’’ Methods:- This is a study design. This study was conducted over 6 months from 2022 to 2023 at aTertiary hospital in an in-patient department. The individuals for whom the inclusion criteriaare taken into consideration. The patients included according to their interests andwillingness in order to carry out the study. The study was conducted in Tertiary Hospital in Guntur [multi-centered hospital]. The study will becarried out foraperiodof6months. Results: Based on gender males are more affected with in the age groupof40-75, in ourresultsout of150the throm bolytics were taken only by 25% of the patients, mostly the CES condition is seen in the patients having cardiac-related problems, thetreatment Conclusion: The rarely diagnosed disease among cardiac-related problems inpatient department of Cardiology and neurology medicine department was found to be a cardioembolic stroke. The most commonly prescribed treatment for CES were TNK (thrombolytic treatment),antiplatelets, anticoagulants, and statins. From This study, we concluded that males (57%) have a high chance to get CES than females (43%). From the study, we conclude that the first line treatment given in CES is thrombolytic therapy, and antiplatelets and statins therapyshows a high impact on CES patients. People who have comorbid conditions like DM (60%)& HTN (69%) have a high chance to get CES from our study, and then neuroprotectants(46%),andanticoagulants (42%)can begiven assecond-linetreatment.

Article Details